光弘科技(300735.SZ):目前公司國內外各基地訂單量較為飽滿
格隆匯1月10日丨光弘科技(300735.SZ)在投資者互動平台表示,2024年,公司訂單量一直處於較好水平,截止已公佈的三季報,營業收入有了不錯的增長。目前公司國內外各基地訂單量較為飽滿,我們也期待在新的一年裏取得更好的佳績。作為專業的電子製造服務商,業務範圍涉及各類電子產品,除了包括手機、平板電腦在內的消費電子和汽車電子產品以外,亦涉及網絡終端、通訊設備、物聯網、新能源、工業控制、醫療電子等諸多領域。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.